These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20816115)

  • 21. Comparison of primary balloon angioplasty with bailout stenting strategy to primary coronary stenting strategy in the treatment of patients with ST-segment elevation myocardial infarction (STEMI).
    Tajstra M; Gasior M; Lekston A; Wilczek K; Hawranek M; Gierlotka M; Słonka G; Zebik T; Poloński L
    Kardiol Pol; 2007 Nov; 65(11):1277-84; discussion 1285-6. PubMed ID: 18058578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London.
    Iqbal MB; Ilsley C; Kabir T; Smith R; Lane R; Mason M; Clifford P; Crake T; Firoozi S; Kalra S; Knight C; Lim P; Malik IS; Mathur A; Meier P; Rakhit RD; Redwood S; Whitbread M; Bromage D; Rathod K; MacCarthy P; Dalby M;
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):936-43. PubMed ID: 25371542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
    Thiele H; Schindler K; Friedenberger J; Eitel I; Fürnau G; Grebe E; Erbs S; Linke A; Möbius-Winkler S; Kivelitz D; Schuler G
    Circulation; 2008 Jul; 118(1):49-57. PubMed ID: 18559698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up.
    Montalescot G; Antoniucci D; Kastrati A; Neumann FJ; Borentain M; Migliorini A; Boutron C; Collet JP; Vicaut E
    Eur Heart J; 2007 Feb; 28(4):443-9. PubMed ID: 17251257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model.
    Klein LW; Shaw RE; Krone RJ; Brindis RG; Anderson HV; Block PC; McKay CR; Hewitt K; Weintraub WS;
    Am J Cardiol; 2005 Jul; 96(1):35-41. PubMed ID: 15979429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Abciximab Therapy in Patients Undergoing Coronary Angioplasty for Acute ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock.
    De Felice F; Tomassini F; Fiorilli R; Gagnor A; Parma A; Cerrato E; Musto C; Nazzaro MS; Varbella F; Violini R
    Circ J; 2015; 79(7):1568-74. PubMed ID: 25912694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial).
    Dangas G; Aymong ED; Mehran R; Tcheng JE; Grines CL; Cox DA; Garcia E; Griffin JJ; Guagliumi G; Stuckey T; Lansky AJ; Stone GW;
    Am J Cardiol; 2004 Oct; 94(8):983-8. PubMed ID: 15476608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
    Guagliumi G; Stone GW; Cox DA; Stuckey T; Tcheng JE; Turco M; Musumeci G; Griffin JJ; Lansky AJ; Mehran R; Grines CL; Garcia E
    Circulation; 2004 Sep; 110(12):1598-604. PubMed ID: 15353506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspiration thrombectomy during primary percutaneous coronary intervention as adjunctive therapy to early (in-ambulance) abciximab administration in patients with acute ST elevation myocardial infarction: an analysis from Leiden MISSION! acute myocardial infarction treatment optimization program.
    Ahmed TA; Atary JZ; Wolterbeek R; Hasan-Ali H; Abdel-Kader SS; Schalij MJ; Jukema JW
    J Interv Cardiol; 2012 Feb; 25(1):1-9. PubMed ID: 22059390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary artery bypass graft surgery provides better survival in patients with acute coronary syndrome or ST-segment elevation myocardial infarction experiencing cardiogenic shock after percutaneous coronary intervention: a propensity score analysis.
    Chiu FC; Chang SN; Lin JW; Hwang JJ; Chen YS
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1326-30. PubMed ID: 19660378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention.
    Bellandi F; Maioli M; Gallopin M; Toso A; Dabizzi RP
    Catheter Cardiovasc Interv; 2004 Jun; 62(2):186-92. PubMed ID: 15170708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of female sex on long-term outcomes in patients with ST-elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Ferrante G; Corrada E; Belli G; Zavalloni D; Scatturin M; Mennuni M; Gasparini GL; Bernardinelli L; Cianci D; Pastorino R; Rossi ML; Pagnotta P; Presbitero P
    Can J Cardiol; 2011; 27(6):749-55. PubMed ID: 21924580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Lindberg S; Pedersen SH; Møgelvang R; Bjerre M; Frystyk J; Flyvbjerg A; Galatius S; Jensen JS
    Am J Cardiol; 2012 Feb; 109(4):492-6. PubMed ID: 22105783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-hospital management and outcome in women with acute myocardial infarction (data from the AMI-Florence Registry).
    Carrabba N; Santoro GM; Balzi D; Barchielli A; Marchionni N; Fabiani P; Landini C; Scarti L; Santoro G; Valente S; Verdiani V; Buiatti E;
    Am J Cardiol; 2004 Nov; 94(9):1118-23. PubMed ID: 15518604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction.
    Chan AW; Chew DP; Bhatt DL; Moliterno DJ; Topol EJ; Ellis SG
    Am J Cardiol; 2002 Jan; 89(2):132-6. PubMed ID: 11792330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
    Pellizzon GG; Grines CL; Cox DA; Stuckey T; Tcheng JE; Garcia E; Guagliumi G; Turco M; Lansky AJ; Griffin JJ; Cohen DJ; Aymong E; Mehran R; O'Neill WW; Stone GW
    J Am Coll Cardiol; 2004 Apr; 43(8):1368-74. PubMed ID: 15093869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prehospital versus periprocedural abciximab in ST-elevation myocardial infarction treated by percutaneous coronary intervention.
    Pels K; Schröder J; Witzenbichler B; Müller D; Morguet A; Pauschinger M; Schultheiss HP; Arntz HR
    Eur J Emerg Med; 2008 Dec; 15(6):324-9. PubMed ID: 19078834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary angioplasty for acute myocardial infarction complicated by cardiogenic shock on admission.
    Rodrigues A; Araújo D; Silva PF; Braga P; Gonçalves M; Simões L; Gama V
    Rev Port Cardiol; 2000 Mar; 19(3):291-7. PubMed ID: 10804775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-hospital and one-year outcomes of patients with high-risk acute myocardial infarction treated with thrombolysis or primary coronary angioplasty.
    Steffenino G; Santoro GM; Maras P; Mauri F; Ardissino D; Violini R; Chiarella F; Lucci D; Marini M; Baldasseroni S; Maggioni AP;
    Ital Heart J; 2004 Feb; 5(2):136-45. PubMed ID: 15086144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of ST resolution analysis performed immediately versus at ninety minutes after primary percutaneous coronary intervention.
    Kumar S; Sivagangabalan G; Hsieh C; Ryding AD; Narayan A; Chan H; Burgess DC; Ong AT; Sadick N; Kovoor P
    Am J Cardiol; 2010 Feb; 105(4):467-74. PubMed ID: 20152240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.